These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32000072)

  • 1. Prediction of treatment resistance in obsessive compulsive disorder patients based on EEG complexity as a biomarker.
    Altuğlu TB; Metin B; Tülay EE; Tan O; Sayar GH; Taş C; Arikan K; Tarhan N
    Clin Neurophysiol; 2020 Mar; 131(3):716-724. PubMed ID: 32000072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study.
    Pallanti S; Bernardi S; Antonini S; Singh N; Hollander E
    CNS Drugs; 2009 Dec; 23(12):1047-55. PubMed ID: 19958042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.
    Tolin DF; Abramowitz JS; Diefenbach GJ
    J Clin Psychiatry; 2005 Dec; 66(12):1549-57. PubMed ID: 16401156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered frontal EEG asymmetry in obsessive-compulsive disorder.
    Ischebeck M; Endrass T; Simon D; Kathmann N
    Psychophysiology; 2014 Jul; 51(7):596-601. PubMed ID: 24673721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.
    Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M
    J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation.
    Pallanti S; Bernardi S; Antonini S; Singh N; Hollander E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):375-80. PubMed ID: 24406025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural Correlates of Response to Pharmacotherapy in Obsessive-Compulsive Disorder: Individualized Cortical Morphology-Based Structural Covariance.
    Yun JY; Jang JH; Kim SN; Jung WH; Kwon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():126-33. PubMed ID: 26116795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of EEG for Predicting Treatment Response to Transcranial Magnetic Stimulation in Obsessive Compulsive Disorder.
    Metin SZ; Balli Altuglu T; Metin B; Erguzel TT; Yigit S; Arıkan MK; Tarhan KN
    Clin EEG Neurosci; 2020 May; 51(3):139-145. PubMed ID: 31583910
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification of obsessive compulsive disorder by EEG complexity and hemispheric dependency measurements.
    Aydin S; Arica N; Ergul E; Tan O
    Int J Neural Syst; 2015 May; 25(3):1550010. PubMed ID: 25804351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear driven compulsive behaviour is associated with worse long-term outcome in obsessive-compulsive disorder.
    Ferreira GM; Albertella L; Moreira-de-Oliveira ME; Piquet-Pessôa M; Yücel M; Lee RSC; Batista KB; de Menezes GB; Fontenelle LF
    Hum Psychopharmacol; 2020 Jan; 35(1):e2720. PubMed ID: 31961460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder.
    Pogarell O; Juckel G; Mavrogiorgou P; Mulert C; Folkerts M; Hauke W; Zaudig M; Möller HJ; Hegerl U
    Int J Psychophysiol; 2006 Oct; 62(1):87-92. PubMed ID: 16554100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
    Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A
    J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative electroencephalography in obsessive-compulsive disorder: preliminary results].
    Fontenelle L; Piedade RA; Marques C; de Menezes GB; Versiani M
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):677-82. PubMed ID: 10973109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metacognitive beliefs predict early response to pharmacological treatment in patients with obsessive-compulsive disorder.
    Park CI; Kim HW; Jeon S; Hwang EH; Kang JI; Kim SJ
    Psychopharmacology (Berl); 2020 Nov; 237(11):3489-3496. PubMed ID: 32748029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients.
    Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T
    Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.